| AHL | apparent half-life |
|---|---|
| AHT | aggregation half time; antihyaluronidase titer; augmented histamine test; autogenous hamster tumor |
| BHL | bilateral hilar lymphadenopathy; biological half-life |
| EHL | effective half-life; electrohydraulic lipotripsy; endogenous hyperlipidemia; Environmental Health La... |
| FWHM | full width at half maximum |
| drug half-life | The amount of time it takes for one-half of an administered drug to be lost through biological processes (metabolism and elimination). (27 Sep 1997) |
|---|---|
| effective half-life | <radiobiology> Time required for a radioactive substance contained in a biological system (such as a person or an animal) to reduce its radioactivity by half, as a combination result of radioactive decay and biological elimination from the system. (09 Oct 1997) |
| elimination half-life | <pharmacology> The time it takes for the body to eliminate or breakdown half of a dose of a pharmacologic agent. (09 Oct 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|